Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
17
At 15, she watched an aunt struggle with breast cancer. Then a cousin. Soon after, Mattie McCalister was stricken with the same disease that would afflict so many of the women in her family.
Though breast cancer is still deadly, it's not as fearsome a diagnosis as it may have been a few decades ago. In 1975, the five-year survival rate was 75 percent. Today, it's 89 percent.
16
I have just been diagnosed with breast cancer, and I want to pursue a holistic approach. What can I do to increase my chances of a successful cure? Here are our eight mind-body tips for a vital and healing journey when diagnosed with cancer.
GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX(R) [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).
NCCN program on Discovery Health Channel profiles patients battling advanced non-small cell lung cancer and highlights their physicians' use of the NCCN Guidelines for Non- Small Cell Lung Cancer in determining the best treatment regimen. The program, which provides free CME credits, premieres on Sunday, October 18 at 7:00 am EDT.
Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek(R) (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.
15
According to recent research from the United States, Context.-Lymphomas involving the breast are rare, and most cases are of B-cell lineage; T-cell neoplasms represent less than 10% of all breast lymphomas. Objective.-To define the clinicopathologic spectrum of anaplastic large cell lymphomas (ALCLs) involving the breast.
According to recent research from the United States, A majority of women with ovarian cancer will face recurrent disease despite receiving aggressive chemotherapy at the time of diagnosis. Given the complex medical and psychosocial needs of women with ovarian cancer and the time constraints within busy clinical settings, providing women with the necessary education related to their disease and treatments can be challenging.
Mayo Clinic researchers have found that certain structural features within breast tissue can indicate a woman's individual cancer risk. The findings appear online today in the Journal of Clinical Oncology.
The statistics from a recent study is startling: Women diagnosed with breast cancer by a routine mammogram have a 95 percent chance of surviving. For women diagnosed later, who haven't received routine mammograms, the chance of dying is 56 percent.
We care about your feedback. Let us know how we can improve your CancerCompass experience.